Veraflox® (pradofloxacin) Oral Suspension for Cats
Prescribing Information for Veterinary Professionals
Veraflox® (pradofloxacin) Oral Suspension for Cats is the next step in veterinary antibiotic therapy for cats. It is approved for the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of:
- Pasteurella multocida
- Streptococcus canis
- Staphylococcus aureus
- Staphylococcus felis
- Staphylococcus pseudintermedius
Veraflox® was designed to improve upon the efficacy against Gram-positive and anaerobic pathogens compared to previous-generation fluoroquinolones while delivering the same Gram-negative activity.*1 It delivers enhanced bactericidal activity by attacking both essential target enzymes necessary for bacterial DNA replication — DNA gyrase and topoisomerase IV — with high affinity.*2 Its demonstrated safety measures include extensive ocular safety testing.3 Veraflox® is approved for use in kittens and cats 12 weeks of age and older.
- Bacterial infections
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law prohibits the extra-label use of this drug in food-producing animals.
CONTRAINDICATIONS: Do not use in dogs. Pradofloxacin has been shown to cause bone marrow suppression in dogs. Pradofloxacin is contraindicated in cats with a known hypersensitivity to quinolones.
WARNINGS: Not for human use. Keep out of reach of children. For use in cats only. The administration of fluoroquinolones for longer than seven days induced reversible leukocyte, neutrophil and lymphocyte decreases in healthy 12-week-old kittens.
PRECAUTIONS: The use of fluoroquinolones in cats has been associated with retinopathy or blindness. Such products should be used with caution in cats. Refer to the product label for a more complete list of risks and precautions.